We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current INTS market cap is 67.05M. The company's latest EPS is USD -0.8651 and P/E is -5.65.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.25M | -1.22M | -2.49M | -3.35M | -4.74M |
| Net Income | -1.34M | -3.7M | -3.65M | -3.17M | -4.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.68M | -6.22M | -8.01M | -7.63M | -8.32M |
| Net Income | -5.38M | -6.03M | -7.9M | -7.58M | -11.86M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 951k | 18.23M | 16.82M | 17.3M | 12.41M |
| Total Liabilities | 6.91M | 3.09M | 905k | 4.13M | 2.69M |
| Total Equity | -15.96M | 15.13M | 15.91M | 13.16M | 9.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.93M | 10.15M | 5.22M | 1.76M | 17.3M |
| Total Liabilities | 1.31M | 1.71M | 3.9M | 6.85M | 4.13M |
| Total Equity | -2.38M | -1.56M | -8.68M | -15.1M | 13.16M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -900k | -1.14M | -6.26M | -7.21M | -4.37M |
| Investing | N/A | N/A | -8.84M | -6.02M | 3.26M |
| Financing | 205k | -37k | 20.48M | 20.47M | 8k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.42M | -5.37M | -6.83M | -5.48M | -7.21M |
| Investing | 1.7M | 4.57M | N/A | N/A | -6.02M |
| Financing | 3.86M | 6.29M | 2.05M | 2.25M | 20.47M |
| Market Cap | 67.05M |
| Price to Earnings Ratio | -5.65 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 7.84 |
| Price to Book Ratio | 5.09 |
| Dividend Yield | - |
| Shares Outstanding | 13.71M |
| Average Volume (1 week) | 17.27k |
| Average Volume (1 Month) | 13.6k |
| 52 Week Change | -15.69% |
| 52 Week High | 11.44 |
| 52 Week Low | 2.0101 |
| Spread (Intraday) | 0.44 (8.56%) |
| Company Name | Intesity Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
